Evidence map›Paper›PMID 34007843›Full record

ArticleERJ open research2021

Sleep apnoea and incident malignancy in type 2 diabetes.

Sarah Driendl, Michael Arzt, Claudia S Zimmermann, Bettina Jung, Tobias Pukrop, Carsten A Böger, Sebastian Haferkamp, Florian Zeman, Iris M Heid, Stefan Stadler

Open access · goldAbstract read
In one paragraph

Article in ERJ open research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Sarah DriendlDept of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.
Michael ArztDept of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.
Claudia S ZimmermannDept of Internal Medicine I, University Hospital Regensburg, Regensburg, Germany.
Bettina JungDept of Nephrology, University Hospital Regensburg, Regensburg, Germany.
Tobias PukropDept of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
Carsten A BögerDept of Nephrology, University Hospital Regensburg, Regensburg, Germany.
Sebastian HaferkampDept of Dermatology, University Hospital Regensburg, Regensburg, Germany.
Florian ZemanCentre of Clinical Studies, University Hospital Regensburg, Regensburg, Germany.
Iris M HeidDept of Genetic Epidemiology, University Hospital Regensburg, Regensburg, Germany.
Stefan StadlerDept of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.
University Hospital Regensburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSleep apnoea and type 2 diabetes (T2D) have been linked to malignancy. The aim of the present study was to evaluate the association between sleep apnoea and incidence of malignancy in patients with T2D.

methodsThe DIACORE (DIAbetes COhoRtE) study is a prospective, population-based cohort study in T2D patients. In the sleep disordered breathing substudy, the apnoea-hypopnoea index (AHI), oxygen desaturation index (ODI) and percentage of night-time spent with a peripheral oxygen saturation of <90% (

resultsOf 1239 patients with T2D (mean age 67 years, 41% female, mean body mass index 30.9 kg·m

conclusionSleep apnoea was not associated with incident malignancy in T2D patients. However, stratified analysis revealed a significant association between sleep apnoea and incident malignancy in females, but not in males.

Identifiers

PMID34007843
PMCPMC8093486
OpenAlexW3132158494

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.